Published Ahead-of-Print - Last Updated: September 14, 2018

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only


Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells

Scaini, Maria Chiara; Pigozzo, Jacopo; Pizzi, Marco; More

Melanoma Research. ., Post Author Corrections: September 14, 2018

Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitors refractory advanced melanoma

Seremet, Teofila; Planken, Simon; Schwarze, Julia K.; More

Melanoma Research. ., Post Author Corrections: September 11, 2018

Osteopenia and fractures associated with long-term therapy with MEK inhibitors

Dumas, Marc; Laly, Pauline; Gottlieb, Jérémy; More

Melanoma Research. ., Post Author Corrections: August 17, 2018


PDF Only


Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma

Tarhini, Ahmad; Ghate, Sameer R.; Ionescu-Ittu, Raluca; More

Melanoma Research. ., Post Author Corrections: September 13, 2018

Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma

Shah, Shalin; Luke, Jason J.; Jacene, Heather A.; More

Melanoma Research. ., Post Author Corrections: September 11, 2018

Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients

Tan, Sally Y.; Najita, Julie; Li, Xiaoxue; More

Melanoma Research. ., Post Author Corrections: August 30, 2018

Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection

Borgognoni, Lorenzo; Bellucci, Francesco; Urso, Carmelo; More

Melanoma Research. ., Post Author Corrections: July 17, 2018

Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlations

Iacono, Donatella; Cinausero, Marika; Gerratana, Lorenzo; More

Melanoma Research. ., Post Author Corrections: May 22, 2018


PDF Only


Show: